Literature DB >> 24532573

Multiple effects of Escherichia coli Nissle 1917 on growth, biofilm formation, and inflammation cytokines profile of Clostridium perfringens type A strain CP4.

Yanlong Jiang1, Qingke Kong, Kenneth L Roland, Amanda Wolf, Roy Curtiss.   

Abstract

Clostridium perfringens is an important Gram-positive pathogen responsible for food poisoning, necrotic enteritis, gas gangrene, and even death. Escherichia coli Nissle 1917 (EcN) is a well-characterized probiotic strain with demonstrated benefits. In this study, we evaluated the effects of EcN on growth, toxin production, biofilm formation, and inflammatory cytokine responses of C. perfringens. In vitro co-culture experiments demonstrated that EcN inhibited growth, gas production, and toxin production (α-toxin and NetB) of C. perfringens in a dose-dependent manner. The growth inhibition effect was not observed when C. perfringens was incubated with EcN cell-free supernatants (CFSE), suggesting that growth inhibition was caused by nutrition competition during co-incubation. In vitro studies demonstrated that pre-incubation with EcN did not inhibit C. perfringens attachment to Caco-2 cells, but did reduce C. perfringens total number, toxin production, and cytotoxicity after 24 h. The similar growth inhibition results were also observed during the formation of C. perfringens biofilm. Finally, pre-incubation of EcN with RAW264.7 cells significantly decreased the production of inflammatory cytokines caused by the introduction of C. perfringens. Our results indicate that EcN can inhibit many of the pathological effects of C. perfringens in vitro conditions.
© 2014 Federation of European Microbiological Societies. Published by John Wiley & Sons Ltd. All rights reserved.

Entities:  

Keywords:  C. perfringens; E. coli Nissle 1917; biofilm; cytokine; inhibition; toxin

Mesh:

Substances:

Year:  2014        PMID: 24532573      PMCID: PMC4038294          DOI: 10.1111/2049-632X.12153

Source DB:  PubMed          Journal:  Pathog Dis        ISSN: 2049-632X            Impact factor:   3.166


  63 in total

Review 1.  Considerations for use of probiotic bacteria to modulate human health.

Authors:  M E Sanders
Journal:  J Nutr       Date:  2000-02       Impact factor: 4.798

Review 2.  Bacterial phospholipases and their role in virulence.

Authors:  J G Songer
Journal:  Trends Microbiol       Date:  1997-04       Impact factor: 17.079

3.  Use of RapidChek® SELECT™ Salmonella to detect shedding of live attenuated Salmonella enterica serovar Typhi vaccine strains.

Authors:  Karen E Brenneman; Caitlin McDonald; Sandra M Kelly-Aehle; Kenneth L Roland; Roy Curtiss
Journal:  J Microbiol Methods       Date:  2012-03-08       Impact factor: 2.363

4.  Inhibition of Clostridium perfringens by a novel strain of Bacillus subtilis isolated from the gastrointestinal tracts of healthy chickens.

Authors:  Alex Yeow-Lim Teo; Hai-Meng Tan
Journal:  Appl Environ Microbiol       Date:  2005-08       Impact factor: 4.792

5.  Inhibition by rapamycin of the lipoteichoic acid-induced granulocyte-colony stimulating factor expression in mouse macrophages.

Authors:  Yuan-Yi Chou; Shao-Chun Lu
Journal:  Arch Biochem Biophys       Date:  2011-02-02       Impact factor: 4.013

Review 6.  The role of probiotic cultures in the prevention of colon cancer.

Authors:  L J Brady; D D Gallaher; F F Busta
Journal:  J Nutr       Date:  2000-02       Impact factor: 4.798

Review 7.  Avian antimicrobial peptides: the defense role of beta-defensins.

Authors:  Haryadi Sugiarto; Pak-Lam Yu
Journal:  Biochem Biophys Res Commun       Date:  2004-10-22       Impact factor: 3.575

Review 8.  Probiotics in prevention of antibiotic associated diarrhoea: meta-analysis.

Authors:  Aloysius L D'Souza; Chakravarthi Rajkumar; Jonathan Cooke; Christopher J Bulpitt
Journal:  BMJ       Date:  2002-06-08

9.  Isolation and characterization of two bacteriocins of Lactobacillus acidophilus LF221.

Authors:  B Bogovic-Matijasić; I Rogelj; I F Nes; H Holo
Journal:  Appl Microbiol Biotechnol       Date:  1998-05       Impact factor: 4.813

10.  Bacterial stimulation of epithelial G-CSF and GM-CSF expression promotes PMN survival in CF airways.

Authors:  Shahryar Saba; Grace Soong; Steven Greenberg; Alice Prince
Journal:  Am J Respir Cell Mol Biol       Date:  2002-11       Impact factor: 6.914

View more
  6 in total

1.  Heparin stimulates biofilm formation of Escherichia coli strain Nissle 1917.

Authors:  Dandan Wu; Xiaomei Li; Yanying Yu; Bingxue Gong; Xianxuan Zhou
Journal:  Biotechnol Lett       Date:  2020-10-04       Impact factor: 2.461

2.  Protective Effects of Lactobacillus plantarum Lac16 on Clostridium perfringens Infection-Associated Injury in IPEC-J2 Cells.

Authors:  Yuanhao Zhou; Baikui Wang; Qi Wang; Li Tang; Peng Zou; Zihan Zeng; Huihua Zhang; Li Gong; Weifen Li
Journal:  Int J Mol Sci       Date:  2021-11-17       Impact factor: 5.923

3.  The effects of probiotic Bacillus subtilis on the cytotoxicity of Clostridium perfringens type a in Caco-2 cell culture.

Authors:  Maryam Poormontaseri; Saeid Hosseinzadeh; Seyed Shahram Shekarforoush; Tahereh Kalantari
Journal:  BMC Microbiol       Date:  2017-07-04       Impact factor: 3.605

4.  Two Lactobacillus Species Inhibit the Growth and α-Toxin Production of Clostridium perfringens and Induced Proinflammatory Factors in Chicken Intestinal Epithelial Cells in Vitro.

Authors:  Shuangshuang Guo; Dan Liu; Beibei Zhang; Zhui Li; Yehan Li; Binying Ding; Yuming Guo
Journal:  Front Microbiol       Date:  2017-10-25       Impact factor: 5.640

5.  Functional investigation of the chromosomal ccdAB and hipAB operon in Escherichia coli Nissle 1917.

Authors:  Jun Xu; Kai Xia; Pinyi Li; Chenggong Qian; Yudong Li; Xinle Liang
Journal:  Appl Microbiol Biotechnol       Date:  2020-06-13       Impact factor: 4.813

6.  The Cu(II) Reductase RclA Protects Escherichia coli against the Combination of Hypochlorous Acid and Intracellular Copper.

Authors:  Rhea M Derke; Alexander J Barron; Caitlin E Billiot; Ivis F Chaple; Suzanne E Lapi; Nichole A Broderick; Michael J Gray
Journal:  mBio       Date:  2020-09-29       Impact factor: 7.867

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.